Daxor Corporation announces two new studies validating the clinical benefits of blood volume analysis (BVA) as a more precise measurement of congestion in ambulatory heart failure (HF) patients. Data from both studies demonstrated a lack of correlation between surrogate measures and actual blood volume, highlighting the necessity for accurate volume measurement, as provided by BVA. The study, ?Impact of Systemic and Pulmonary Afterload on the Pressure-Volume Relationship in Heart Failure Using Direct Blood Volume Measurement,?

was presented at the American College of Cardiology Scientific Sessions 2024. The study, Prognostic Implications of Volume Status Assessed by Blood Volume Analysis in Ambulatory Heart Failure,? was authored by heart failure experts from Duke University Medical Center, Baptist Memorial Hospital and Banner University Medical Center.